These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27748980)

  • 1. Tensins are versatile regulators of Rho GTPase signalling and cell adhesion.
    Blangy A
    Biol Cell; 2017 Mar; 109(3):115-126. PubMed ID: 27748980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tensin 3 is a new partner of Dock5 that controls osteoclast podosome organization and activity.
    Touaitahuata H; Morel A; Urbach S; Mateos-Langerak J; de Rossi S; Blangy A
    J Cell Sci; 2016 Sep; 129(18):3449-61. PubMed ID: 27505886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The phosphotyrosine-independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1.
    Liao YC; Si L; deVere White RW; Lo SH
    J Cell Biol; 2007 Jan; 176(1):43-9. PubMed ID: 17190795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dock-family exchange factors in cell migration and disease.
    Gadea G; Blangy A
    Eur J Cell Biol; 2014 Oct; 93(10-12):466-77. PubMed ID: 25022758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities.
    Qian X; Li G; Asmussen HK; Asnaghi L; Vass WC; Braverman R; Yamada KM; Popescu NC; Papageorge AG; Lowy DR
    Proc Natl Acad Sci U S A; 2007 May; 104(21):9012-7. PubMed ID: 17517630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The focal adhesion-associated proteins DOCK5 and GIT2 comprise a rheostat in control of epithelial invasion.
    Frank SR; Köllmann CP; van Lidth de Jeude JF; Thiagarajah JR; Engelholm LH; Frödin M; Hansen SH
    Oncogene; 2017 Mar; 36(13):1816-1828. PubMed ID: 27669437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of the activity of deleted in liver cancer 1 (DLC1) by tensins controls cell migration and transformation.
    Cao X; Voss C; Zhao B; Kaneko T; Li SS
    Proc Natl Acad Sci U S A; 2012 Jan; 109(5):1455-60. PubMed ID: 22307599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Full activity of the deleted in liver cancer 1 (DLC1) tumor suppressor depends on an LD-like motif that binds talin and focal adhesion kinase (FAK).
    Li G; Du X; Vass WC; Papageorge AG; Lowy DR; Qian X
    Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17129-34. PubMed ID: 21969587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fibronectin-binding integrins alpha5beta1 and alphavbeta3 differentially modulate RhoA-GTP loading, organization of cell matrix adhesions, and fibronectin fibrillogenesis.
    Danen EH; Sonneveld P; Brakebusch C; Fassler R; Sonnenberg A
    J Cell Biol; 2002 Dec; 159(6):1071-86. PubMed ID: 12486108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ARAP3 is transiently tyrosine phosphorylated in cells attaching to fibronectin and inhibits cell spreading in a RhoGAP-dependent manner.
    I ST; Nie Z; Stewart A; Najdovska M; Hall NE; He H; Randazzo PA; Lock P
    J Cell Sci; 2004 Dec; 117(Pt 25):6071-84. PubMed ID: 15546919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phosphorylation switch controls the spatiotemporal activation of Rho GTPases in directional cell migration.
    Cao X; Kaneko T; Li JS; Liu AD; Voss C; Li SS
    Nat Commun; 2015 Jul; 6():7721. PubMed ID: 26166433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rho GAPs and GEFs: controling switches in endothelial cell adhesion.
    van Buul JD; Geerts D; Huveneers S
    Cell Adh Migr; 2014; 8(2):108-24. PubMed ID: 24622613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular and clinical role of Tensin 1/2/3 in cancer.
    Mainsiouw L; Ryan ME; Hafizi S; Fleming JC
    J Cell Mol Med; 2023 Jul; 27(13):1763-1774. PubMed ID: 37296531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DLC1 SAM domain-binding peptides inhibit cancer cell growth and migration by inactivating RhoA.
    Joshi R; Qin L; Cao X; Zhong S; Voss C; Min W; Li SSC
    J Biol Chem; 2020 Jan; 295(2):645-656. PubMed ID: 31806702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of subcellular targeting sequences of Cten reveals its role in cell proliferation.
    Hong SY; Shih YP; Lo A; Lo SH
    Biochim Biophys Acta Mol Cell Res; 2019 Mar; 1866(3):450-458. PubMed ID: 30321615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rho regulation: DLC proteins in space and time.
    Braun AC; Olayioye MA
    Cell Signal; 2015 Aug; 27(8):1643-51. PubMed ID: 25889896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of deleted in liver cancer 1 with tensin2 in caveolae and implications in tumor suppression.
    Yam JW; Ko FC; Chan CY; Jin DY; Ng IO
    Cancer Res; 2006 Sep; 66(17):8367-72. PubMed ID: 16951145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P-Rex1 directly activates RhoG to regulate GPCR-driven Rac signalling and actin polarity in neutrophils.
    Damoulakis G; Gambardella L; Rossman KL; Lawson CD; Anderson KE; Fukui Y; Welch HC; Der CJ; Stephens LR; Hawkins PT
    J Cell Sci; 2014 Jun; 127(Pt 11):2589-600. PubMed ID: 24659802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deleted in liver cancer 1 (DLC1) utilizes a novel binding site for Tensin2 PTB domain interaction and is required for tumor-suppressive function.
    Chan LK; Ko FC; Ng IO; Yam JW
    PLoS One; 2009; 4(5):e5572. PubMed ID: 19440389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid recruitment of p120RasGAP and its associated protein, p190RhoGAP, to the cytoskeleton during integrin mediated cell-substrate interaction.
    Sharma SV
    Oncogene; 1998 Jul; 17(3):271-81. PubMed ID: 9690509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.